Larissa Paulasto

ELZA researchers report 12-month outcomes for a second-generation sub400 cross-linking protocol that extends CXL to ultra-thin keratoconus and post-LASIK ectasia corneas below 400 micrometres, halting progression in 76% of eyes while shortening treatment to about 18 minutes.
From 12–15 September 2025, the ELZA team will be at the ESCRS Annual Meeting in Copenhagen. Learn more…
Larissa Paulasto shares her insights from the 19th International Myopia Conference in Sanya, China, where she discussed her research on myopia management lenses.
.
.